CorMedix Launches Catheter Lock Product In Germany, Looks Ahead To U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is shipping Neutrolin, a device containing an antimicrobial/antifungal agent and two anti-clotting agents, in Germany to “lock” catheters between dialysis sessions and prevent blood stream infections and clots. The New Jersey firm also is working with FDA to get the product approved in the U.S. as a specialty pharmaceutical.